A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer (Q36623473)
scientific article published on July 2001
Language:
(P31) (Q13442814)
(P275) (Q15643954)
(P304) 152-156
(P407) (Q1860)
(P433) 2
(P478) 85
(P577) Sunday, July 1, 2001
(P921) (Q181257)
(P1433) (Q326309)
(P1476) "A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer" (language: en)
(P2093) James ND
Atherton PJ
Jones J
Howie AJ
Tchekmedyian S
Curnow RT
(P2860) (Q40636291)
(Q24682910)
(Q33502081)
(Q38474353)
(Q39498879)
(Q35650579)
(Q24569561)
(Q41615181)
(Q41682845)
(Q47685354)
(Q42436009)
(Q32054825)
(Q25938997)
(Q74463745)
(Q77435880)
(Q77526189)
(Q77995576)
(Q72083450)
(Q72237384)
(Q60015062)
(Q69090836)
(Q67667124)
(Q74545980)
(P6216) (Q50423863)
other details
description scientific article published on July 2001

External Links